<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0062">
 <label>62</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Boulahjar</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ouach</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bourg</surname>
    <given-names>S</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2015</year>;
  <volume>101</volume>:
  <fpage>274</fpage>–
  <lpage>87</lpage>.
  <pub-id pub-id-type="pmid">26142492</pub-id>
 </mixed-citation>
</ref>
